{"id":"https://openalex.org/W4397042275","doi":"https://doi.org/10.1681/asn.20233411s1972c","title":"Post Hoc Analyses of Biomarkers Predictive of a Renal Response to Intravenous (IV) Belimumab (BEL) Plus Standard Therapy (ST) in Patients with Lupus Nephritis (LN)","display_name":"Post Hoc Analyses of Biomarkers Predictive of a Renal Response to Intravenous (IV) Belimumab (BEL) Plus Standard Therapy (ST) in Patients with Lupus Nephritis (LN)","publication_year":2023,"publication_date":"2023-11-01","ids":{"openalex":"https://openalex.org/W4397042275","doi":"https://doi.org/10.1681/asn.20233411s1972c"},"language":"en","primary_location":{"id":"doi:10.1681/asn.20233411s1972c","doi":"https://doi.org/10.1681/asn.20233411s1972c","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.20233411s1972c","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042356850","display_name":"Brad H. Rovin","orcid":"https://orcid.org/0000-0001-5639-0210","observed_orcids":["https://orcid.org/0000-0001-5639-0210"]},"institutions":[{"id":"https://openalex.org/I2802841970","display_name":"The Ohio State University Wexner Medical Center","ror":"https://ror.org/00c01js51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brad H. Rovin","raw_affiliation_strings":["Ohio State University Wexner Medical Center, Columbus, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ohio State University Wexner Medical Center, Columbus, OH;","institution_ids":["https://openalex.org/I2802841970"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076651506","display_name":"Richard Alan Furie","orcid":"https://orcid.org/0000-0001-6712-1585","observed_orcids":["https://orcid.org/0000-0001-6712-1585"]},"institutions":[{"id":"https://openalex.org/I139290212","display_name":"Hofstra University","ror":"https://ror.org/03pm18j10","country_code":"US","type":"education","lineage":["https://openalex.org/I139290212"]},{"id":"https://openalex.org/I4210106353","display_name":"Donald & Barbara Zucker School of Medicine at Hofstra/Northwell","ror":"https://ror.org/01ff5td15","country_code":"US","type":"education","lineage":["https://openalex.org/I1302444339","https://openalex.org/I139290212","https://openalex.org/I4210106353"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Furie","raw_affiliation_strings":["Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY;","institution_ids":["https://openalex.org/I139290212","https://openalex.org/I4210106353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022937823","display_name":"Ana Malvar","orcid":"https://orcid.org/0000-0003-1609-3857","observed_orcids":["https://orcid.org/0000-0003-1609-3857"]},"institutions":[{"id":"https://openalex.org/I4210096133","display_name":"Hospital Fern\u00e1ndez","ror":"https://ror.org/00tdzhd41","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210096133"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Ana Malvar","raw_affiliation_strings":["Hospital Fernandez, Buenos Aires, Argentina;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Fernandez, Buenos Aires, Argentina;","institution_ids":["https://openalex.org/I4210096133"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015927371","display_name":"Cynthia B. Aranow","orcid":"https://orcid.org/0000-0001-9299-0053","observed_orcids":["https://orcid.org/0000-0001-9299-0053"]},"institutions":[{"id":"https://openalex.org/I1327576362","display_name":"Feinstein Institute for Medical Research","ror":"https://ror.org/05dnene97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1302444339","https://openalex.org/I1327576362"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cynthia Aranow","raw_affiliation_strings":["Feinstein Institutes for Medical Research, Manhasset, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Feinstein Institutes for Medical Research, Manhasset, NY;","institution_ids":["https://openalex.org/I1327576362"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036618124","display_name":"Jos\u00e9 Mar\u00eda Pego\u2010Reigosa","orcid":"https://orcid.org/0000-0003-3461-3537","observed_orcids":["https://orcid.org/0000-0003-3461-3537"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jos\u00e9 M. Pego-Reigosa","raw_affiliation_strings":["Complexo Hospitalario Universitario de Vigo, Hospital Meixoeiro, Vigo, Spain;","Galicia Sur Health Research Institute and IRIDIS (Investigation in Rheumatology and Immune-Mediated Diseases) Group, Vigo, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Complexo Hospitalario Universitario de Vigo, Hospital Meixoeiro, Vigo, Spain;","institution_ids":[]},{"raw_affiliation_string":"Galicia Sur Health Research Institute and IRIDIS (Investigation in Rheumatology and Immune-Mediated Diseases) Group, Vigo, Spain;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034644063","display_name":"Elena Zakharova","orcid":"https://orcid.org/0000-0003-0178-7549","observed_orcids":["https://orcid.org/0000-0003-0178-7549"]},"institutions":[{"id":"https://openalex.org/I4210121251","display_name":"Botkin Hospital","ror":"https://ror.org/01xbp4f63","country_code":"RU","type":"healthcare","lineage":["https://openalex.org/I4210121251"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Elena Zakharova","raw_affiliation_strings":["Moscow City Clinical Hospital n.a. S.P. Botkin, Moscow, Russian Federation;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moscow City Clinical Hospital n.a. S.P. Botkin, Moscow, Russian Federation;","institution_ids":["https://openalex.org/I4210121251"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050678710","display_name":"Andreas Schwarting","orcid":"https://orcid.org/0000-0002-0566-598X","observed_orcids":["https://orcid.org/0000-0002-0566-598X"]},"institutions":[{"id":"https://openalex.org/I197323543","display_name":"Johannes Gutenberg University Mainz","ror":"https://ror.org/023b0x485","country_code":"DE","type":"education","lineage":["https://openalex.org/I197323543"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andreas Schwarting","raw_affiliation_strings":["University Center of Autoimmunity, Mainz, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Center of Autoimmunity, Mainz, Germany;","institution_ids":["https://openalex.org/I197323543"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030384538","display_name":"Angela R. Jones-Leone","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angela R. Jones-Leone","raw_affiliation_strings":["GSK, Collegeville, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Collegeville, PA;","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023279987","display_name":"Jennifer Gilbride","orcid":"https://orcid.org/0000-0003-3958-0308","observed_orcids":["https://orcid.org/0000-0003-3958-0308"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer A. Gilbride","raw_affiliation_strings":["GSK, Stevenage, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Stevenage, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036222488","display_name":"Beulah Ji","orcid":"https://orcid.org/0000-0002-9944-348X","observed_orcids":["https://orcid.org/0000-0002-9944-348X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Beulah Ji","raw_affiliation_strings":["GSK, Shanghai, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Shanghai, China;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034488510","display_name":"David A. Roth","orcid":"https://orcid.org/0000-0001-8356-0457","observed_orcids":["https://orcid.org/0000-0001-8356-0457"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A. Roth","raw_affiliation_strings":["GSK, Collegeville, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Collegeville, PA;","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089088362","display_name":"Paula S. Curtis","orcid":"https://orcid.org/0000-0001-9808-5468","observed_orcids":["https://orcid.org/0000-0001-9808-5468"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paula S. Curtis","raw_affiliation_strings":["GSK, Brentford, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Brentford, United Kingdom","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049035796","display_name":"Andr\u00e9 van Maurik","orcid":"https://orcid.org/0000-0002-1954-0141","observed_orcids":["https://orcid.org/0000-0002-1954-0141"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andr\u00e9 van Maurik","raw_affiliation_strings":["GSK, Stevenage, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Stevenage, United Kingdom;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.33758326,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":"11S","first_page":"972","last_page":"973"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lupus-nephritis","display_name":"lupus nephritis","score":0.9760000109672546},{"id":"https://openalex.org/keywords/belimumab","display_name":"belimumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.671999990940094},{"id":"https://openalex.org/keywords/renal-response","display_name":"renal response","score":0.6850000023841858},{"id":"https://openalex.org/keywords/anti-c1q-autoantibodies","display_name":"anti-C1q autoantibodies","score":0.8450000286102295},{"id":"https://openalex.org/keywords/immunoglobulin-a","display_name":"immunoglobulin A","score":0.8949999809265137},{"id":"https://openalex.org/keywords/naive-b-cells","display_name":"naive B cells","score":0.7739999890327454},{"id":"https://openalex.org/keywords/plasmablasts","display_name":"plasmablasts","score":0.9070000052452087},{"id":"https://openalex.org/keywords/igm","display_name":"IgM","score":0.5080000162124634},{"id":"https://openalex.org/keywords/urine-protein-creatinine-ratio","display_name":"urine protein-to-creatinine ratio","score":0.7599999904632568},{"id":"https://openalex.org/keywords/anti-dsdna-antibodies","display_name":"anti-dsDNA antibodies","score":0.8309999704360962},{"id":"https://openalex.org/keywords/complement-c3-and-c4","display_name":"complement C3 and C4","score":0.8569999933242798},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.41200000047683716}],"concepts":[{"id":"https://openalex.org/C2781205201","wikidata":"https://www.wikidata.org/wiki/Q1996249","display_name":"Belimumab","level":5,"score":0.9538923501968384},{"id":"https://openalex.org/C2779912601","wikidata":"https://www.wikidata.org/wiki/Q1621830","display_name":"Lupus nephritis","level":3,"score":0.8551205992698669},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8290103673934937},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.7353505492210388},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5555602312088013},{"id":"https://openalex.org/C2992886853","wikidata":"https://www.wikidata.org/wiki/Q18381816","display_name":"Post hoc","level":2,"score":0.46753522753715515},{"id":"https://openalex.org/C2777058396","wikidata":"https://www.wikidata.org/wiki/Q401402","display_name":"Nephritis","level":2,"score":0.41931936144828796},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.35987740755081177},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.33337074518203735},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.33115142583847046},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2941284477710724},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.14352309703826904},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.1388406753540039},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.0},{"id":"https://openalex.org/C170286685","wikidata":"https://www.wikidata.org/wiki/Q409346","display_name":"B-cell activating factor","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1681/asn.20233411s1972c","doi":"https://doi.org/10.1681/asn.20233411s1972c","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.20233411s1972c","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7156281045","https://openalex.org/W4294598225","https://openalex.org/W7133194120","https://openalex.org/W4313532444","https://openalex.org/W4297374645","https://openalex.org/W3204257182","https://openalex.org/W3212222180","https://openalex.org/W4397025070","https://openalex.org/W3038221340","https://openalex.org/W4384627186"],"abstract_inverted_index":{"Background:":[0],"In":[1],"BLISS-LN":[2,66],"(GSK":[3,290],"BEL114054),":[4],"a":[5,129,134,146,179,189,195,235,614,619,676,699],"Phase":[6],"3":[7],"trial":[8],"of":[9,65,70,81,94,109,142,157,163,169,214,234,244,262,278,308,728],"adults":[10],"with":[11,14,72,131,136,153,628,689],"LN":[12,73],"treated":[13],"BEL":[15,24,82,132,154,239,251,267,282,330,334],"10":[16],"mg/kg/month":[17],"IV":[18],"or":[19,183,283,612,654,675,753,780],"placebo":[20],"(PBO),":[21],"+":[22],"ST,":[23],"resulted":[25],"in":[26,44,104,148,181,191,197,208,224,228,237,258,273,426,446,468,489,509,530,553,575,703],"significantly":[27],"more":[28,747,774],"kidney":[29,309],"responses":[30,276],"(Primary":[31],"Efficacy":[32,810],"Renal":[33,38,797,811],"Response":[34,39],"[PERR]":[35],"and":[36,41,46,49,52,100,133,145,159,171,178,194,213,222,246,298,643,707],"Complete":[37,796],"[CRR]),":[40],"greater":[42],"improvements":[43],"anti-dsDNA":[45,490],"anti-C1q":[47,127,209,510,531],"autoantibodies":[48],"complement":[50],"C3":[51],"C4":[53],"levels":[54,99,141,162,243],"than":[55,748,775],"PBO":[56,137,328,332],"over":[57],"104":[58,313,323,327,735,762],"weeks":[59],"(wks).":[60],"This":[61],"post":[62,316,620],"hoc":[63,87,317,621],"analysis":[64],"assessed":[67],"the":[68,79,92,105,238,606,626,704,713],"characteristics":[69],"patients":[71,122,280],"most":[74],"likely":[75],"to":[76,83,111,173,204,303,659,663,680,684,709,718],"benefit":[77],"from":[78,301,618,657,678],"addition":[80],"ST.":[84],"Methods:":[85],"Post":[86],"logistic":[88,622],"regression":[89,623],"models":[90],"tested":[91],"ability":[93],"potential":[95],"baseline":[96,641,644],"(BL)":[97],"biomarker":[98,101,297,306],"level":[102],"changes":[103],"first":[106],"12":[107,218,579],"months":[108],"treatment":[110,611],"predict":[112],"PERR":[113,130,170,190,221,263,320],"and/or":[114,264],"CRR":[115,135,172,203,223,265,324],"at":[116,150,185,199,210,216,250,311,321,325,338,355,372,392,408,429,449,471,492,512,533,558,578,733,739,760,766],"Wk":[117,151,186,200,211,217,312,322,326,734,740,761,767],"104.":[118],"Results:":[119],"Overall,":[120],"446":[121],"were":[123,155,167,231,723],"evaluated.":[124],"High":[125,139,242],"BL":[126,140,161,176,296,302,339,356,373,393,409,652,658,673,679],"predicted":[128,188,202,220,260,275],"(Table).":[138],"immunoglobulin":[143],"(Ig)A":[144],"decrease":[147,180,196,677],"IgA":[149,182,198,245,336,427,447],"8":[152,430],"predictive":[156,168,233],"PERR,":[158,808],"high":[160],"na\u00efve":[164,247],"B":[165,248,389,555],"cells":[166,249,390,556],"BEL.":[174,205],"Low":[175],"plasmablasts,":[177],"IgM":[184,353,469],"24":[187,201,450,472,493,513,559],"both":[192,225],"groups":[193],"A":[206],"reduction":[207],"52":[212,534],"uPCR":[215,274,576,743,770],"also":[219],"groups.":[226],"Changes":[227],"B-cell":[229],"subsets":[230],"not":[232,269,694,724,731,814],"response":[236,310,729],"group.":[240],"Conclusions:":[241],"initiation,":[252],"as":[253,255],"well":[254],"early":[256],"reductions":[257,272],"IgA,":[259],"attainment":[261],"for":[266,625,698],"but":[268],"PBO.":[270,284],"Early":[271],"regardless":[277],"whether":[279,605],"received":[281],"Funding:":[285],"Commercial":[286],"Support":[287],"-":[288,294,342,344,345,360,361,362,376,379,415,434,436,437,456,478,479,498,499,500,518,520,564,565,566],"GSK":[289],"BEL114054;":[291],"NCT01639339)":[292],"Table.":[293],"Significant":[295],"percentage":[299],"change":[300,702],"stated":[304,660,681],"wks":[305,431,451,473,494,514,535,560,580,661,682],"prediction":[307],"(treatment":[314],"policy*;":[315],"analysis)":[318],"Predictor":[319],"(n=223)":[329,331,333,335],"(g/l)":[337,354,428,448,470],"Parameter":[340,357,374,394,410,432,452,474,495,515,536,561,581,687],"estimate\u2020":[341,358,375,395,411,433,453,475,496,516,537,562,582],"0.3341":[343],"Odds":[346,363,380,398,416,438,458,480,501,521,542,567,587,720],"ratio\u2021":[347,364,381,399,417,439,459,481,502,522,543,568,588],"ns":[348,351,352,367,368,369,382,387,400,403,424,440,443,444,464,486,487,505,506,507,525,528,571,572,573],"1.40,":[349],"p=0.0173":[350],"0.6674":[359],"1.95,":[365],"p=0.0120":[366],"Anti-C1q":[370],"(U/ml)":[371,511,532],"0.002391":[377],"0.001615":[378],"1.0024,":[383],"p=0.0148":[384],"1.0016,":[385],"p=0.0192":[386],"Naive":[388],"(count/\u03bcl)":[391,557],"0.001730":[396],"0.001688":[397],"1.0017,":[401,404],"p=0.0433":[402],"p=0.0446":[405],"Plasmablasts":[406],"(count/ml)":[407],"-0.000166":[412],"-0.000111":[413],"-0.000193":[414],"0.9998,":[418,422],"p=0.0124":[419],"0.9999,":[420],"p=0.0398":[421],"p=0.0268":[423],"Change":[425,445,467,488,508,529,552,574],"-0.0199":[435],"0.98,":[441,460,465,484],"p=0.0482":[442],"-0.0155":[454],"-0.0332":[455],"-0.0171":[457],"p=0.0471":[461],"0.97,":[462],"p=0.0003":[463],"p=0.0456":[466],"-0.0132":[476],"-0.0152":[477],"0.99,":[482],"p=0.0174":[483],"p=0.0171":[485],"(IU/ml)":[491],"-0.004507":[497],"0.9955,":[503],"p=0.0204":[504],"-0.018157":[517],"-0.011071":[519],"0.9820,":[523],"p=0.0002":[524],"0.9890,":[526],"p=0.0190":[527,549],"-0.012990":[538],"-0.016034":[539],"-0.011426":[540],"-0.013112":[541],"0.9871,":[544],"p=0.0020":[545],"0.9841,":[546],"p=0.0055":[547],"0.9886,":[548],"0.9870,":[550],"p=0.0219":[551],"memory":[554],"0.004601":[563],"1.0046,":[569],"p=0.0466":[570],"(g/g)":[577],"-0.5611":[583],"-0.3763":[584],"-0.8469":[585],"-0.3696":[586],"0.57,":[589],"p<0.0001":[590,594],"0.69,":[591,595],"p=0.0018":[592],"0.43,":[593],"p=0.0094":[596],"*Treatment":[597],"policy":[598],"population":[599],"included":[600],"all":[601],"available":[602],"data,":[603],"ignoring":[604],"patient":[607],"had":[608],"discontinued":[609],"study":[610],"started":[613],"prohibited":[615],"medication;\u2020estimates":[616],"are":[617,693,697,730],"model":[624],"parameter":[627,647,668],"covariates":[629],"induction":[630],"regimen":[631],"(CYC":[632],"vs":[633,639],"MMF),":[634],"race":[635],"(Black":[636],"African":[637],"ancestry":[638],"other),":[640],"uPCR,":[642,816],"eGFR.":[645],"Positive":[646],"estimates":[648,669,688],"indicate":[649,670],"that":[650,671,722],"higher":[651],"values":[653,674],"an":[655],"increase":[656],"lead":[662,683],"better":[664,685],"response.":[665,686],"Conversely,":[666],"negative":[667],"lower":[672],"non-significant":[690],"odds":[691,714],"ratios":[692,696,715,721],"displayed;\u2021odds":[695],"one":[700],"unit":[701],"lab":[705],"parameter,":[706],"due":[708],"this":[710],"small":[711],"scale,":[712],"appear":[716],"close":[717],"1.":[719],"statistically":[725],"significant":[726],"predictors":[727],"displaved.PERR":[732],"(Wk":[736,763],"100.":[737],"confirmed":[738,765],"104)":[741,768],"=":[742,769],"\u22640.7,":[744],"eGFR":[745,772],"no":[746,757,773,784],"20%":[749],"below":[750,777],"pre-flare":[751,778],"value":[752,779],"\u226560":[754],"ml/min/1.73":[755,782],"m2,":[756,783],"rescue":[758,785],"therapy.CRR":[759],"100,":[764],"<0.5,":[771],"10%":[776],"\u226590":[781],"therapy.BEL,":[786],"belimumab;":[787],"BL,":[788],"baseline;":[789],"CYC,":[790],"cyclophosphamide;":[791],"MMF,":[792],"mycophenolate":[793],"mofetil;":[794],"CRR,":[795],"Response;":[798],"eGFR,":[799],"estimated":[800],"glomerular":[801],"filtration":[802],"rate;":[803],"Ig,":[804],"Immunoglobulin;":[805],"PBO,":[806],"placebo;":[807],"Primary":[809],"Response,":[812],"ns,":[813],"significant;":[815],"urine":[817],"protein/creatinine":[818],"ratio.":[819]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2024-05-19T00:00:00"}